Click to Share
 

US Embolotherapy Trends Press Releases

Exclusive News
Topics Locations Industries Dates

By P&S Intelligence
The U.S. embolotherapy market is set to grow at a 7.9% CAGR, reaching $2.69B by 2032, driven by rising chronic diseases, tech advancements, and minimal invasiveness.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share